Company / Operating Cash Flow per Share
Bicara Therapeutics Inc. Operating Cash Flow per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.00
FY2024
5-year range
-$0.08 / -$0.00
FY2023-FY2024
Trend
+94.3%
vs FY2023
Sector context
#76 of 212
Health Care
What the data says
At $-0.00, Bicara Therapeutics Inc.'s operating cash flow per share ranks #76 of 212 in the Health Care sector.
Based on SEC 10-K filings.
-0.00 in FY2024.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 212 in Health CareTop 36% of 212This company -$0.00 Sector average $5.28
▼
-100.1% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 94.3% year-over-year.
- Ranks #76 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.00 | +94.3% |
| FY2023 | -$0.08 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026